نتائج البحث - "Glenn S. Kroog"

1

Incidence of Second Primary Malignancies (SPMs) in Patients in the US with Triple-Class-Exposed (TCE) Relapsed or Refractory Multiple Myeloma (RRMM)

المؤلفون: Wenzhen Ge, Alexi Archambault, Thomas E. Delea, Karen Rodriguez Lorenc, James Harnett, Aaron Moynahan, Derek Weycker, Yariv Houvras, Glenn S. Kroog, Ning Wu, Christian Hampp, Qiufei Ma

المصدر: Blood. 140:10897-10899

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8da64ed4cc032cdcac7d679db4b84c6a
https://doi.org/10.1182/blood-2022-158013

2

Trial in Progress: REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase Ib Multi-Cohort Study of Combination Regimens for Patients with Relapsed/Refractory Multiple Myeloma

المؤلفون: Paula Rodríguez Otero, Nisha S. Joseph, Shaji K Kumar, Hans C. Lee, Xavier Leleu, Salomon Manier, Meletios A. Dimopoulos, María Victoria Mateos, Albert Oriol, Naresh Bumma, Weiying Gong, Pourab Roy, Karen Rodriguez Lorenc, Glenn S. Kroog, Shawn M. Sarkaria

المصدر: Blood. 140:4444-4446

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0b9376e7f0877699812d8e6cf7045167
https://doi.org/10.1182/blood-2022-157713

3

Real-World Study of Patients with Triple-Class Exposed Relapsed or Refractory Multiple Myeloma: Analysis across a Spectrum of Advanced Disease Stage Patients in the United States

المؤلفون: Qiufei Ma, Xue Song, Thomas E. Delea, Glenn S. Kroog, Wenzhen Ge, Lei Chi, Aaron Moynahan, Derek Weycker, Karen Rodriguez Lorenc

المصدر: Blood. 140:5298-5300

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a5f6356f9e9691f319ab3e7044cca9b0
https://doi.org/10.1182/blood-2022-158142

4

Trial in Progress: A Phase II Window of Opportunity Study of the BCMAxCD3 Bispecific Antibody REGN5458 in Previously Untreated Patients with Symptomatic Multiple Myeloma

المؤلفون: Christopher J. Ferreri, Steven E. Quatela, Sean Aina, Pourab Roy, Anita Boyapati, Karen Rodriguez Lorenc, Glenn S. Kroog, Robert Z. Orlowski

المصدر: Blood. 140:10129-10130

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2ddcc50fd78f156e0b888cbb42fca851
https://doi.org/10.1182/blood-2022-158396

5

Prevalence of Ocular Comorbidities in Elderly Patients with Multiple Myeloma in the US: An Analysis of 100% Medicare Sample Data during 2007-2020

المؤلفون: Sikander Ailawadhi, Qiufei Ma, Jessica J. Jalbert, Mo Zhou, Zheng-Yi Zhou, Nathaniel Downes, Adina Zhang, Lei Chi, Christian Hampp, Xue Song, Irene Noguera-Troise, Jonathan Weyne, Glenn S. Kroog, Karen Rodriguez Lorenc

المصدر: Blood. 140:5272-5273

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::764b66a46120045d72aa33fd33654808
https://doi.org/10.1182/blood-2022-158401

6

Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study

المصدر: Blood. 140:10140-10141

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::45b0ed2730650e2f9341b7e5ed3ea2ab
https://doi.org/10.1182/blood-2022-159969

7

MM-087 Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma

المؤلفون: Jeffrey A. Zonder, Joshua Richter, Naresh Bumma, Jason Brayer, James E. Hoffman, William I. Bensinger, Ka Lung Wu, Linzhi Xu, Dhruti Chokshi, Anita Boyapati, Damien Cronier, Yariv Houvras, Karen Rodriguez Lorenc, Glenn S. Kroog, Madhav V. Dhodapkar, Suzanne Lentzsch, Dennis Cooper, Sundar Jagannath

المصدر: Clinical Lymphoma Myeloma and Leukemia. 22:S406-S407

مصطلحات موضوعية: Cancer Research, Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::65adcde05ae90789089a34985a106763
https://doi.org/10.1016/s2152-2650(22)01591-9

View record from ScienceDirect

Full Text via ClinicalKey

8

Poster: MM-087 Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma

المؤلفون: Jeffrey A. Zonder, Joshua Richter, Naresh Bumma, Jason Brayer, James E. Hoffman, William I. Bensinger, Ka Lung Wu, Linzhi Xu, Dhruti Chokshi, Anita Boyapati, Damien Cronier, Yariv Houvras, Karen Rodriguez Lorenc, Glenn S. Kroog, Madhav V. Dhodapkar, Suzanne Lentzsch, Dennis Cooper, Sundar Jagannath

المصدر: Clinical Lymphoma Myeloma and Leukemia. 22:S178

مصطلحات موضوعية: Cancer Research, Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::79f11717a1dfda55458be48d59657b0d
https://doi.org/10.1016/s2152-2650(22)01098-9

View record from ScienceDirect

Full Text via ClinicalKey

9

OAB-056: Early, deep, and durable responses, and low rates of cytokine release syndrome with REGN5458, a BCMAxCD3 bispecific antibody, in a Phase 1/2 study in patients with relapsed/refractory multiple myeloma

المؤلفون: Jeffrey Zonder, Joshua Richter, Naresh Bumma, Jason Brayer, James E. Hoffman, William I. Bensinger, Ka Lung Wu, Linzhi Xu, Dhruti Chokshi, Anita Boyapati, Damien Cronier, Yariv Houvras, Karen Rodriguez Lorenc, Glenn S. Kroog, Madhav V. Dhodapkar, Suzanne Lentzsch, Dennis Cooper, Sundar Jagannath

المصدر: Clinical Lymphoma Myeloma and Leukemia. 22:S35

مصطلحات موضوعية: Cancer Research, Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::be713534e3573b08903651ab6923bd4e
https://doi.org/10.1016/s2152-2650(22)00329-9

View record from ScienceDirect

Full Text via ClinicalKey

10

Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios

المؤلفون: Neil P. Shah, Philip A. Rowlings, Jorge E. Cortes, François Xavier Mahon, Kyna Gooden, Philipp le Coutre, Glenn S. Kroog, Jiří Mayer, Giuseppe Saglio, Milayna Subar

المصدر: Annals of hematology, vol 96, iss 8
Annals of Hematology

مصطلحات موضوعية: Oncology, Male, Outcome Assessment, Dasatinib, Cardiorespiratory Medicine and Haematology, Cardiovascular, 0302 clinical medicine, Prednisone, Ischemia, hemic and lymphatic diseases, Outcome Assessment, Health Care, Antineoplastic Combined Chemotherapy Protocols, Ischemic, Medicine, Chronic, Clinical Trials as Topic, Leukemia, Incidence (epidemiology), Incidence, Chronic myeloid leukemia, Hematology, General Medicine, Middle Aged, Docetaxel, Cardiovascular Diseases, 030220 oncology & carcinogenesis, Original Article, Female, medicine.drug, Adult, medicine.medical_specialty, Immunology, Placebo, 03 medical and health sciences, Outcome Assessment (Health Care), Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Humans, Risk factor, Intensive care medicine, Protein Kinase Inhibitors, Aged, Tyrosine kinase inhibitors, business.industry, Prostatic Neoplasms, Imatinib, Clinical trial, Health Care, BCR-ABL Positive, business, 030215 immunology, Myelogenous

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65800c0b628baa5f98ecc1e11eafcdee
https://escholarship.org/uc/item/1361k75x

تنقيح النتائج